Close
Achema middle east
swop processing & packaging

News

FUJIFILM Announces License Agreement with Novo Nordisk for the Development of iPSC-Derived Cell Therapies

FUJIFILM Cellular Dynamics, Inc., a leading global developer and manufacturer of human induced pluripotent stem cells (iPSC), announced that it has entered an agreement to...

Aurisco to Build Oligonucleotides Manufacturing Facility in China

Aurisco, a pharmaceutical company and contract development and manufacturing organization (CDMO) in China, is cooperating with global life sciences company Cytiva, to build its first...

Sartorius, RoosterBio Partner to Advance the Manufacture of Exosomes

Sartorius has extended a strategic collaboration agreement with RoosterBio Inc. to address purification challenges and establish scalable downstream manufacturing processes for exosome-based therapies. The companies...

GHO Capital and The Vistria Group Complete Acquisition of Leading CDMO Alcami Corporation

Global Healthcare Opportunities, or GHO Capital Partners LLP ("GHO"), and The Vistria Group today announced that they have completed the acquisition of Alcami Corporation ("Alcami"),...

Duality Biologics Announces License Agreement of its Next-generation ADC platform with Adcendo

Duality Biologics, a clinical-stage biotech company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers and autoimmune diseases, announced a license...

Agilent Technologies Inc. Acquires Avida Biomed

Agilent Technologies Inc. has acquired Avida Biomed, an early-stage life sciences company that develops high-performance target enrichment workflows with unique capabilities for clinical researchers utilizing next-generation...

Capsida Biotherapeutics, Prevail Therapeutics Enter Strategic R&D Alliance

Capsida Biotherapeutics Inc. has entered a multi-year strategic collaboration with Prevail Therapeutics, a wholly owned subsidiary of Eli Lilly and Co., to develop genetic medicines...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »